1335 Arginase-1 vaccine promotes T cell immunity against arginase-1+ cells, controls tumor growth via immune modulation of tumor microenvironment

• Marco Carretta,
• Mads H Andersen,
• Erika Sutanto-Ward,
• Inés Lecoq,
• Evelina Martinenaite,
• Mia Aaboe Jørgensen,
• Preeyam Patel,
• Marion Chapellier,
• Ayako Pedersen,
• Shih-Chun Shen,
• Alex J Muller

Affiliations

Marco Carretta

National Center for Cancer Immunotherapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

Mads H Andersen

Aff1 grid.411900.d0000000406468325Center for Cancer Immune Therapy, Department of HaematologyCopenhagen University Hospital at Herlev Herlev Denmark

Erika Sutanto-Ward

2Lankenau Institute for Medical Research, Wynnewood, PA, USA

Inés Lecoq

National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

Evelina Martinenaite

1IO Biotech, Copenhagen, Denmark

Mia Aaboe Jørgensen

National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

Preeyam Patel

IO Biotech, Copenhagen, Denmark

Marion Chapellier

IO Biotech, Copenhagen, Denmark

Ayako Pedersen

IO Biotech, Copenhagen, Denmark

Shih-Chun Shen

4Drexel University College of Medicine, Philadelphia, PA, USA

Alex J Muller

3Lankenau Institute for Medical Research, Wynnewood, PA, USA